ZFIN ID: ZDB-FISH-170227-8
Fish name: mu240Tg
Genotype: mu240Tg
Targeting Reagent: none
HUMAN DISEASE MODELED by mu240Tg
No data available
GENE EXPRESSION
Gene expression in mu240Tg
RNA expression No data available
Protein expression No data available
PHENOTYPE
Phenotype in mu240Tg
Phenotype Conditions Figures
brain vasculature angiogenic sprout fusion process quality, abnormal chemical treatment by environment: IWR-1-endo Fig. 2 from Hübner et al., 2018
brain vasculature branching involved in blood vessel morphogenesis process quality, abnormal chemical treatment by environment: IWR-1-endo Fig. 2 from Hübner et al., 2018
central artery amount, ameliorated chemical treatment by environment: IWR-1-endo, chemical treatment by environment: VPC 23019 Fig. 5 from Hübner et al., 2018
central artery amount, ameliorated chemical treatment by environment: IWR-1-endo, chemical treatment by environment: TY 52156 Fig. 5 from Hübner et al., 2018
central artery attached to central artery, abnormal chemical treatment by environment: IWR-1-endo Fig. 2 from Hübner et al., 2018
central artery attachment quality basilar artery, abnormal chemical treatment by environment: IWR-1-endo Fig. 2 from Hübner et al., 2018
central artery decreased amount, abnormal chemical treatment by environment: IWR-1-endo, chemical treatment by environment: NSC 23766 trihydrochloride Fig. 6 from Hübner et al., 2018
central artery decreased amount, abnormal chemical treatment by environment: IWR-1-endo Fig. 2Fig. 5Fig. 6 from Hübner et al., 2018
central artery blood vessel lumenization decreased process quality, abnormal chemical treatment by environment: IWR-1-endo Fig. 5Fig. 6 from Hübner et al., 2018
central artery blood vessel lumenization process quality, ameliorated chemical treatment by environment: IWR-1-endo, chemical treatment by environment: NSC 23766 trihydrochloride Fig. 6 from Hübner et al., 2018
central artery blood vessel lumenization process quality, ameliorated chemical treatment by environment: IWR-1-endo, chemical treatment by environment: VPC 23019 Fig. 5 from Hübner et al., 2018
central artery blood vessel lumenization process quality, ameliorated chemical treatment by environment: IWR-1-endo, chemical treatment by environment: TY 52156 Fig. 5 from Hübner et al., 2018
common cardinal vein width, normal chemical treatment by environment: latrunculin A Fig. 5 with image from Hamm et al., 2016
common cardinal vein width, normal chemical treatment by environment: blebbistatin Fig. 5 with image from Hamm et al., 2016
common cardinal vein actin filament bundle disoriented, abnormal chemical treatment by environment: (S)-2-methyl-1-(4-methylisoquinoline-5-sulfonyl)-1,4-diazepane Fig. 5 with image from Hamm et al., 2016
common cardinal vein actin filament bundle organization decreased process quality, abnormal chemical treatment by environment: (S)-2-methyl-1-(4-methylisoquinoline-5-sulfonyl)-1,4-diazepane Fig. 5 with image from Hamm et al., 2016
common cardinal vein blood vessel endothelium patchy, abnormal chemical treatment by environment: (S)-2-methyl-1-(4-methylisoquinoline-5-sulfonyl)-1,4-diazepane Fig. 5 with image from Hamm et al., 2016
common cardinal vein blood vessel endothelium patchy, abnormal chemical treatment by environment: latrunculin A Fig. 5 with image from Hamm et al., 2016
common cardinal vein blood vessel endothelium patchy, abnormal chemical treatment by environment: blebbistatin Fig. 5 with image from Hamm et al., 2016
common cardinal vein cell-cell junction decreased length, abnormal chemical treatment by environment: (S)-2-methyl-1-(4-methylisoquinoline-5-sulfonyl)-1,4-diazepane Fig. 5 with image from Hamm et al., 2016
common cardinal vein cell-cell junction length, normal chemical treatment by environment: nifedipine, chemical treatment by environment: tricaine Fig. 6 with image from Hamm et al., 2016
endothelial tip cell filopodium normal length, normal control Fig. 5 with image from Kempers et al., 2021

CITATIONS  (3)